Mentis Cura   Report issue

For profit
Founded: Reykjavík Iceland (2004)
Status: Left NME R&D (2009)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2004

Timeline

NOW
  • Now

Active Ingredients

Drugs in Other Trials (1)

scopolamine (transderm scop) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1